BEST VITELLIFORM MACULAR DYSTROPHY

Clinical trials for BEST VITELLIFORM MACULAR DYSTROPHY explained in plain language.

Never miss a new study

Get alerted when new BEST VITELLIFORM MACULAR DYSTROPHY trials appear

Sign up with your email to follow new studies for BEST VITELLIFORM MACULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

One-Shot eye injection aims to halt rare genetic vision loss

Disease control Recruiting now

This early-stage study is testing a one-time gene therapy injection for two rare, inherited eye diseases that cause progressive vision loss: Best vitelliform macular dystrophy (BVMD) and Autosomal-Recessive Bestrophinopathy (ARB). Researchers will give the experimental drug, OPGx…

Matched conditions: BEST VITELLIFORM MACULAR DYSTROPHY

Phase: PHASE1, PHASE2 • Sponsor: Opus Genetics, Inc • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

BEST VITELLIFORM MACULAR DYSTROPHY

Get alerted when new BEST VITELLIFORM MACULAR DYSTROPHY trials appear

One-Shot eye injection aims to halt rare genetic vision loss